International Cardio events

More information>>>

20 International congress of updates in cardiology 6-9 June 2024, Istanbul, Turkey More information at >>>

More information>>>

INTERNATIONAL HEART CONGRESS 2023 23-25 May, Tokyo, Japan More information at >>>

The 33rd Great Wall International Cardiology Conference 28-30 October 2022, Beijing, China More information at >>>

CBC TOGETHER WITH WCC 2022 13-15 October 2022, Rio de Janeiro, Brazil More information at >>>

Prolactin Tied to Poorer Diastolic Function in Men With Type 2 Diabetes Higher prolactin levels were associated with poorer diastolic function and worse New York Heart Association functional class, a marker of heart failure severity, in men with type 2 diabetes but not in women. However, prolactin showed no association with systolic function, lipid levels, or A1c levels in either sex.

Ovarian Reserve Decline Patterns Linked to Cardiovascular Risk After Menopause According to a new study, patterns of decreased ovarian reserve during the transition to menopause may be associated with cardiovascular risk after menopause.

Bipolar Disorder Linked to Higher Risk for Cardiovascular Disease A meta-analysis has shown that adults with bipolar disorder (BPD) have a significant number of cardiovascular diseases (CVD). Controlled observational studies have shown a higher incidence of cardiovascular complications among people with BPD than among people without BPD.

Healthy Diet May Curb Heart Disease Risk in Cancer Survivors Cancer survivors who adhered to the Dietary Approaches to Stop Hypertension (DASH) diet and other healthy eating patterns showed as much as a one-third lower risk of developing cardiovascular disease over 12 years vs their peers who did not follow those dietary patterns.

Timeless therapeutics: cardiac indications for vitamin K antagonists in clinical practice Anticoagulation is a critical component in the treatment of cardiovascular diseases. Large randomised controlled trials have demonstrated that direct oral anticoagulants (DOACs) are effective and safe for stroke prevention in patients with atrial fibrillation (AF) and treatment or prevention of venous thromboembolism.

CARDIOPROGRESS
Foundation for the advancement of cardiology